Changing the lives


Millions of women

Learn more
Early diagnosis

Early diagnostic

can limit disease progression

and its consequences

Learn more
Guiding decisions


personalized medicine

Learn more
New therapies

Support the rise


new therapies

Learn more

Who we are

About us

Endodiag vision is that we can radically change the lives of millions of women suffering from endometriosis through earlier and easier diagnosis and radically improved disease management.
We develop new endometriosis diagnostic solutions for healthcare professionals. These solutions are intended to contribute to a better endometriosis diagnosis, a more personalized patient management, more efficient treatment options and fertility strategy.

Learn more about us


A misunderstood and misdiagnosed disease


Endometriosis affects 10% of all women of reproductive age

Endometriosis is caused by tissue, that usually lines inside the uterus, developing outside the uterus.


Severe but non-specific symptoms

Patients with endometriosis present with a variety of symptoms, most notably chronic pelvic pain (75% of patients) and infertility (up to 40%)


Major diagnostic delays

Endometriosis is often misdiagnosed or remains undiagnosed for a long period of time.


No permanent cure

There's no permanent cure for endometriosis so far. Symptom relief is the primary goal of existing treatment options combining surgery and hormonal therapies

Endodiag works on

Early diagnosis

The first blood test for endometriosis detection

Currently only the removal of endometriosis lesions via surgery and their lab analysis allows the diagnosis with certainty. The average diagnosis delay is about 7 to 11 years. Endodiag develops a non-invasive and reliable diagnostic test based on disease-specific biomarkers circulating in the blood. Such a test will allow physicians to prevent disease progression and potentially safeguard fertility.

Learn more

Guiding decisions

Mapping disease and help surgeons assess the best therapeutic strategy for each patient

Each patient endometriosis is unique so should be its treatment. This is why we are developing a solution to map the patient disease. This will help physicians to assess the best treatment and fertility strategy for each patient.

Learn more

New therapies

Understand the molecular mechanisms of endometriosis to give rise to new targeted therapies

Current therapies only address the symptoms and not the root causes. As a result, disease recurrence is frequent. There is a considerable need for novel targeted therapies without side effects, allowing pregnancy during treatment and prevent disease recurrence. Endodiag partners with teams working specifically on new drug development by bringing its know-how and technology.

Learn more


  • ENDOrun Paris 2019

    ENDOrun Paris 2019

    The second mixed race organized for endometriosis research in France will take place on Sunday, November 10. The first edition gathered 1400 participants…
  • AAGL congrès 2019

    AAGL congress 2019

    We will be present and happy to meet you at the American Association of Gynecologic laparoscopists congress (AAGL) from 9 to 13 of october in…
  • 75ème congrès de l'ASRM

    75th ASRM Scientific congress

    Endodiag will be present on the 75th American Society for Reproductive Medicine Scientific Congress & Expo (ASRM). The congress will be held on october…
  • 5ème congrès de La SEUD

    5th congress of the SEUD

    The 5th Congress of the Society of Endometriosis and Uterine Disorders (SEUD) will be held on May 16-18 in Montreal, Canada. Do not hesitate to contact…